Literature DB >> 15758166

Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Angela M Floden1, Shanshan Li, Colin K Combs.   

Abstract

Although abundant reactive microglia are found associated with beta-amyloid (Abeta) plaques in Alzheimer's disease (AD) brains, their contribution to cell loss remains speculative. A variety of studies have documented the ability of Abeta fibrils to directly stimulate microglia in vitro to assume a neurotoxic phenotype characterized by secretion of a plethora of proinflammatory molecules. Collectively, these data suggest that activated microglia play a direct role in contributing to neuron death in AD rather than simply a role in clearance after plaque deposition. Although it is clear the Abeta-stimulated microglia acutely secrete toxic oxidizing species, the identity of longer-lived neurotoxic agents remains less defined. We used Abeta-stimulated conditioned media from primary mouse microglia to identify more stable neurotoxic secretions. The NMDA receptor antagonists memantine and 2-amino-5-phosphopetanoic acid as well as soluble tumor necrosis factor alpha (TNFalpha) receptor protect neurons from microglial-conditioned media-dependent death, implicating the excitatory neurotransmitter glutamate and the proinflammatory cytokine TNFalpha as effectors of microglial-stimulated death. Neuron death occurs in an oxidative damage-dependent manner, requiring activity of inducible nitric oxide synthase. Toxicity results from coincident stimulation of the TNFalpha and NMDA receptors, because stimulations of either alone are insufficient to initiate cell death. These findings suggest the hypothesis that AD brains provide the appropriate microglial-mediated inflammatory environment for TNFalpha and glutamate to synergistically stimulate toxic activation of their respective signaling pathways in neurons as a contributing mechanism of cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758166      PMCID: PMC6725188          DOI: 10.1523/JNEUROSCI.4998-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Metalloporphyrins are potent inhibitors of lipid peroxidation.

Authors:  B J Day; I Batinic-Haberle; J D Crapo
Journal:  Free Radic Biol Med       Date:  1999-03       Impact factor: 7.376

3.  Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.

Authors:  N G Carlson; W A Wieggel; J Chen; A Bacchi; S W Rogers; L C Gahring
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

4.  A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.

Authors:  H D Venters; Q Tang; Q Liu; R W VanHoy; R Dantzer; K W Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide.

Authors:  M Noda; H Nakanishi; N Akaike
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

Authors:  V D Bianca; S Dusi; E Bianchini; I Dal Prà; F Rossi
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

7.  Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

Authors:  E Tarkowski; K Blennow; A Wallin; A Tarkowski
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

8.  Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD.

Authors:  A J Bruce-Keller; J W Geddes; P E Knapp; R W McFall; J N Keller; F W Holtsberg; S Parthasarathy; S M Steiner; M P Mattson
Journal:  J Neuroimmunol       Date:  1999-01-01       Impact factor: 3.478

9.  A high plasma concentration of TNF-alpha is associated with dementia in centenarians.

Authors:  H Bruunsgaard; K Andersen-Ranberg; B Jeune; A N Pedersen; P Skinhøj; B K Pedersen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-07       Impact factor: 6.053

10.  Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma.

Authors:  D Galimberti; P Baron; L Meda; E Prat; E Scarpini; R Delgado; A Catania; J M Lipton; G Scarlato
Journal:  Biochem Biophys Res Commun       Date:  1999-09-16       Impact factor: 3.575

View more
  92 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.

Authors:  Min Guo; Jian Wang; Yanxin Zhao; Yiwei Feng; Sida Han; Qiang Dong; Mei Cui; Kim Tieu
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

4.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

5.  Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

Authors:  Masaru Yamamoto; Tomomi Kiyota; Masahide Horiba; James L Buescher; Shannon M Walsh; Howard E Gendelman; Tsuneya Ikezu
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

6.  Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice.

Authors:  Susan A Austin; Colin K Combs
Journal:  Neurobiol Aging       Date:  2008-12-05       Impact factor: 4.673

Review 7.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Trends Immunol       Date:  2008-07-01       Impact factor: 16.687

8.  Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production.

Authors:  Qing-Shan Xue; D Larry Sparks; Wolfgang J Streit
Journal:  J Neuroinflammation       Date:  2007-08-24       Impact factor: 8.322

9.  RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.

Authors:  Fang Fang; Lih-Fen Lue; Shiqiang Yan; Hongwei Xu; John S Luddy; Doris Chen; Douglas G Walker; David M Stern; Shifang Yan; Ann Marie Schmidt; John X Chen; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2009-11-11       Impact factor: 5.191

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.